MammoSTAR®
Biopsy Site Marker
Providing a non-metal marking alternative with a long-lasting beta glucan carrier plug for unique patient sensitivities.
MammoSTAR® Biopsy Site Marker
Provides a Naturally Reassuring Option
The MammoSTAR® marker offers a non-metallic option composed of all natural minerals, Carbon Coated Zirconium Oxide and lyophilized beta-glucan gel (or simple sugar).
Enables Enhanced Long-Term Ultrasound Visibility
The MammoSTAR® marker provides enhanced long-term ultrasound visibility to allow easier pre-surgery localization.1
Two natural, non-metal shapes for better tracking of multiple biopsy sites
Shapes
- Barbell (also available in a petite carrier)
- Tribell
Frequently Asked Questions
Do the MammoSTAR® markers provide enhanced ultrasound visibility?
Yes, the lyophilized beta-glucan gel (or simple sugar) provides enhanced long-term ultrasound visibility to allow easier pre-surgery localization.2
What is the MammoSTAR® marker composed of?
The MammoSTAR® marker is a pyrolytic carbon coating while the carrier is a lyophilized beta-glucan gel or simple sugar.
Does the MammoSTAR® marker contain nickel?
The MammoSTAR® marker does not contain nickel.
Related Products
HydroMARKTM Breast Biopsy Site Marker
Enduring exclusive hydrogel technology provides long-term ultrasound visibility in percutaneous breast biopsy procedures, including axillary lymph nodes.3
HydroMARKTM Plus Breast Biopsy Site Marker
Same great benefits of the original HydroMARKTM markers, with added features designed to alleviate displacement, enhance visibility and ease of locating.4,5,6
MammoMARK® & CorMARK® Biopsy Site Identifier
Rapid collagen expansion anchors the marker within the biopsy cavity reducing the likelihood of movement.7,8
LumiMARKTM Biopsy Site Marker
Three multifaceted nitinol shapes designed for easy identification from any angle.9
BiomarC® Biopsy Site Marker
All-natural design in a small size, ideal for superficial lesions.
1. Mammotome Data: visibility and localization
2. Mammotome Data: visibility
3. Indication for lymph node using HydroMARKTM markers is limited to the United States with other country registrations pending.
4. HydroMARKTM Device Test – PCR-000414, Summative Usability
5. HydroMARKTM Design Plan – ADD-00013 Rev G, Page 15
6. HydroMARKTM Device Test – PCR-000299, SDR0098 Vacuum Suction Testing
7. MammoMARK® Device Test – PRC043442 Rev B, pgs. 2, 5-6: Collagen Expansion
8. Corsi, F., Sorrentino, L., Sartani, A., Bossi, D., Amadori, R., Nebuloni, M., Truffi, M., Bonzini, M., & Foschi, D. (2015). Localization of nonpalpable breast lesions with sonographically visible clip: Optimizing tailored resection and clear margins.The American Journal of Surgery, 209(6), 950-958
9. LumiMARKTM Device Tests: PCR-000340 System Design, PCR-000579 Summative Usability, ES-002647 Claims Assessment
Products may not be approved or available in your region. Please check with your local Mammotome representative.